Vaccine | Abbreviation | Manufacturer | Recommended storage | Trade name (Brand) | Route of administration |
---|---|---|---|---|---|
Haemophilus influenzae type b vaccine | HiB | GSK | 2–8 °C | HIBERIX | Intramuscular |
Measles, mumps, and rubella vaccine | MMR | MERCK | 2–8 °C | M-M-R II | Subcutaneous |
Meningococcal polysaccharide vaccine (quadrivalent) | MPSV4 | Sanofi Pasteur | 2–8 °C | Menomune-A/C/Y/W-135 | Subcutaneous |
Measles and rubella virus vaccine | MR | Serum | 2–8 °C | MR-Vac | Subcutaneous |
Yellow Fever Vaccine | YF | Sanofi Pasteur | 2–8 °C | Yf-Vax | Subcutaneous |
`Bacillus Calmette–Guerin (Bacterial Vaccine) | BCG | Serum | 2–8 °C | TUBERVAC | Intradermal |
Rabies Vaccine | – | Serum | 2–8 °C | RABIVAX-S | Intramuscular |
Measles Vaccine | MCV | Serum | 2–8 °C | M-Vac | Subcutaneous |
Measles, Mumps and Rubella Vaccine | MMR | Serum | 2–8 °C | TRESIVAC | Subcutaneous |
Rubella Vaccine | - | Serum | 2–8 °C | R-VAC | Subcutaneous |
Rotavirus Vaccine | RV | Serum | 2–8 °C | ROTASIIL | Oral |
Influenza Vaccine (Trivalent) | IIV3 | Serum | 2–8 °C | NASOVAC-S | Intranasal |
Haemophilus b Conjugate Vaccine | HiB | Sanofi Pasteur | 2–8 °C | ActHIB | Intramuscular |
Bacillus Calmette–Guerin strain | BCG | Serum | 2–8 °C | SII-ONCO-BCG | Intravesical Instillation |
measles and rubella vaccine | MR | Merck | 2–8 °C | M-R-VAX II | Subcutaneous |
Measles, Mumps, Rubella and Varicella | MMRV | Merck | 2–8 °C | ProQuad | Subcutaneous |
Meningococcal,Hib (Groups CY-Hib) | HibMenCY-TT | GSK | 2–8 °C | MENHIBRIX | Intramuscular |
Rotavirus (Monovalent) | RV1 | GSK | 2–8 °C | ROTARIX | Oral |
Herpes Zoster | RZV | Merck | 2–8 °C | ZOSTAVAX | Subcutaneous |
Varicella | VAR | Merck | 2–8 °C | VARIVAX | Subcutaneous |
Rabies | – | Novartis | 2–8 °C | RabAvert | Intramuscular |
Rabies | – | Sanofi Pasteur | 2–8 °C | Imovax | Intramuscular |